Sheila A. Mathias's most recent trade in Virpax Pharmaceuticals Inc was a trade of 112,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on Jan. 29, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Virpax Pharmaceuticals Inc | Sheila A. Mathias | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2024 | 112,000 | 112,000 | - | - | Stock Option (right to buy) |